Application of Treat to Target and Impact of Sustained Low Disease Activity or Remission on Function in Psoriatic Arthritis Patients

被引：0
|
作者：
Rahman, Proton [1 ]
Arendse, Regan [2 ]
Baer, Philip [3 ]
Zummer, Michel [4 ]
Rampakakis, Emmanouil [5 ]
Lehman, Allen [6 ]
Rachich, Meagan [6 ]
Nantel, Francois [6 ]
Asin-Milan, Odalis [6 ]
机构：
[1] Mem Univ, St John, NF, Canada
[2] Univ Saskatchewan, Saskatoon, SK, Canada
[3] Baer Weinberg MPC, Scarborough, ON, Canada
[4] Univ Montreal, Dept Med, Montreal, PQ, Canada
[5] JSS Med Res Inc, Montreal, PQ, Canada
[6] Janssen Inc, Toronto, ON, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2020年 / 47卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
168
引用
收藏
页码：1103 / 1104
页数：2
相关论文
共 50 条
  • [21] Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort
    van Mens, Leonieke J. J.
    van de Sande, Marleen G. H.
    van Kuijk, Arno W. R.
    Baeten, Dominique
    Coates, Laura C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (02) : 251 - 257
  • [22] Impact of Disease Activity on Physical Activity in Patients With Psoriatic Arthritis
    Hernandez-Hernandez, Maria Vanesa
    Sanchez-Perez, Hiurma
    Luna-Gomez, Cristina
    Ferraz-Amaro, Ivan
    Diaz-Gonzalez, Federico
    ARTHRITIS CARE & RESEARCH, 2021, 73 (12) : 1834 - 1844
  • [23] MINIMAL DISEASE ACTIVITY IN PSORIATIC ARTHRITIS PREDICTS LOW IMPACT OF DISEASE
    Kasavkar, Ganesh
    Banerjee, Siwalik
    Gullick, Nicola
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1274 - 1275
  • [24] CERTOLIZUMAB PEGOL PROVIDES SUSTAINED REMISSION AND MINIMAL DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS OVER 4 YEARS' TREATMENT
    van der Heijde, D.
    Deodhar, A.
    FitzGerald, O.
    Fleischmann, R.
    Gladman, D.
    Gottlieb, A. B.
    Coates, L. C.
    Hoepken, B.
    Bauer, L.
    Peterson, L.
    Khraishi, M.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1027 - 1027
  • [25] Validation of New Potential Targets for Remission and Low Disease Activity in Psoriatic Arthritis in Patients Treated with Golimumab
    Coates, Laura
    Rahman, Proton
    Psaradellis, Eliofotisti
    Rampakakis, Emmanouil
    Osborne, Brendan
    Lehman, Allen
    Nantel, Francois
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 995 - 995
  • [26] Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab
    Coates, Laura C.
    Rahman, Proton
    Psaradellis, Eliofotisti
    Rampakakis, Emmanouil
    Osborne, Brendan
    Lehman, Allen J.
    Nantel, Francois
    RHEUMATOLOGY, 2019, 58 (03) : 522 - 526
  • [27] Validation of New Potential Targets for Remission and Low Disease Activity in Psoriatic Arthritis in Patients Treated with Golimumab
    Coates, Laura C.
    Rahman, Proton
    Psaradellis, Eliofotisti
    Rampakakis, Emmanouil
    Osborne, Brendan
    Lehman, Allen J.
    Nantel, Francois
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [28] POST-EFFORT SYNOVIAL AND ENTHESIC RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS IN REMISSION OF LOW DISEASE ACTIVITY
    Guillen-Astete, C.
    Zurita-Prada, P.
    Urrego-Laurin, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 761 - 761
  • [29] IMPACT OF PSORIASIS REMAINS IMPORTANT IN PSORIATIC ARTHRITIS PATIENTS WITH LOW MUSCULOSKELETAL DISEASE ACTIVITY
    Kasiem, F. R.
    Kok, M. R.
    Luime, J.
    Tchetverikov, I.
    Wervers, K.
    Hazes, J.
    Vis, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 868 - 869
  • [30] Impact of psoriasis remains important in psoriatic arthritis patients with low musculoskeletal disease activity
    Kasiem, F. R.
    Kok, M. R.
    Luime, J. J.
    Tchetverikov, I.
    Wervers, K.
    Korswagen, L-a.
    Denissen, N.
    Goekoop-Ruiterman, Y. P. M.
    van Oosterhout, M.
    Fodili, F.
    Hazes, J. M. W.
    Vis, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (01) : 88 - 93
12345